164 related articles for article (PubMed ID: 38333510)
21. Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.
Hussain RM; Ciulla TA
Expert Opin Biol Ther; 2016; 16(3):365-74. PubMed ID: 26674182
[TBL] [Abstract][Full Text] [Related]
22. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.
Braithwaite T; Nanji AA; Lindsley K; Greenberg PB
Cochrane Database Syst Rev; 2014 May; 2014(5):CD007325. PubMed ID: 24788977
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials.
Gao L; Zhao X; Jiao L; Tang L
Eye Vis (Lond); 2021 Oct; 8(1):35. PubMed ID: 34629111
[TBL] [Abstract][Full Text] [Related]
24. Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results.
Savur F; Kaldırım H; Atalay K; Korkmaz Ş
Cutan Ocul Toxicol; 2021 Dec; 40(4):326-331. PubMed ID: 34275395
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic interventions for preventing macular edema after cataract surgery in patients with diabetes: A Bayesian network meta-analysis of randomized controlled trials.
Zhang R; Dong L; Yang Q; Liu Y; Li H; Zhou W; Wu H; Li Y; Li Y; Yu C; Wei W
EClinicalMedicine; 2022 Jul; 49():101463. PubMed ID: 35747191
[TBL] [Abstract][Full Text] [Related]
26. Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study.
Shimura M; Kitano S; Muramatsu D; Fukushima H; Takamura Y; Matsumoto M; Kokado M; Kogo J; Sasaki M; Morizane Y; Kotake O; Koto T; Sonoda S; Hirano T; Ishikawa H; Mitamura Y; Okamoto F; Kinoshita T; Kimura K; Sugimoto M; Yamashiro K; Suzuki Y; Hikichi T; Washio N; Sato T; Ohkoshi K; Tsujinaka H; Kusuhara S; Kondo M; Takagi H; Murata T; Sakamoto T;
Br J Ophthalmol; 2020 Sep; 104(9):1209-1215. PubMed ID: 31784500
[TBL] [Abstract][Full Text] [Related]
27. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
Hu Q; Li H; Xu W; Du Y; Ma C; He J
Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
[TBL] [Abstract][Full Text] [Related]
28. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis.
Qian TW; Zhao MY; Li XX; Xu X
Int J Ophthalmol; 2017; 10(7):1134-1143. PubMed ID: 28730118
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients.
Li YF; Ren Q; Sun CH; Li L; Lian HD; Sun RX; Su X; Yu H
World J Diabetes; 2022 Jul; 13(7):532-542. PubMed ID: 36051431
[TBL] [Abstract][Full Text] [Related]
30. Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema.
Gurung RL; FitzGerald LM; Liu E; McComish BJ; Kaidonis G; Ridge B; Hewitt AW; Vote BJ; Verma N; Craig JE; Burdon KP
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409401
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M
Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.
Namvar E; Yasemi M; Nowroozzadeh MH; Ahmadieh H
Semin Ophthalmol; 2024 Jan; 39(1):109-119. PubMed ID: 37621098
[TBL] [Abstract][Full Text] [Related]
33. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
[TBL] [Abstract][Full Text] [Related]
34. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
Arıkan Yorgun M; Toklu Y; Mutlu M
Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal ranibizumab (lucentis) for the treatment of diabetic macular edema: a systematic review and meta-analysis of randomized clinical control trials.
Wang H; Sun X; Liu K; Xu X
Curr Eye Res; 2012 Aug; 37(8):661-70. PubMed ID: 22631452
[TBL] [Abstract][Full Text] [Related]
36. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.
Liu W; Li Y; Cao R; Bai Z; Liu W
Medicine (Baltimore); 2020 May; 99(21):e20222. PubMed ID: 32481293
[TBL] [Abstract][Full Text] [Related]
37. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
38. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.
Qian T; Zhao M; Xu X
J Clin Pharm Ther; 2017 Oct; 42(5):519-529. PubMed ID: 28639290
[TBL] [Abstract][Full Text] [Related]
39. Comparison of micropulse subthreshold laser plus anti-VEGF versus anti-VEGF alone in diabetic macular edema: Systematic review.
Lubis PM; Prabaniswara MP; Victor AA
Indian J Ophthalmol; 2023 Nov; 71(11):3448-3453. PubMed ID: 37870005
[TBL] [Abstract][Full Text] [Related]
40. An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data.
Muston D; Korobelnik JF; Reason T; Hawkins N; Chatzitheofilou I; Ryan F; Kaiser PK
BMC Ophthalmol; 2018 Dec; 18(1):340. PubMed ID: 30591022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
